MedTrace Logo

Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

NCT03486665 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-07-19

No results posted yet for this study

Summary

Multiple sclerosis (MS) is a chronic progressive neurological autoimmune disease, that gradually affects patient's quality of life. There are about 2.5 millions patients world wide, with an increasing cost Burdon. Up to date, it remains unclear who are the exact cells to initiate the disease. During the disease, the repertoire of cells expands and undergoes changes. The purpose of this study is to characterize those changes.

Conditions

Interventions

OTHER

Blood Sampling

Blood samples will be taken from all patients and healthy volunteers.

OTHER

CSF Sampling

CSF sample will be taken from hospitalized newly diagnosed patients only.

Sponsors & Collaborators

  • Bioimmunate

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2018-09-30
Completion
2020-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03486665 on ClinicalTrials.gov